2017 American Academy of Pediatrics Clinical Practice Guideline: Impact on Prevalence of Arterial Hypertension in Children and Adolescents With Type 1 Diabetes.

{"article_title":"2017 American Academy of Pediatrics Clinical Practice Guideline: Impact on Prevalence of Arterial Hypertension in Children and Adolescents With Type 1 Diabetes.","author":"Dost, Axel , Bechtold, Susanne , Fink, Katharina , Bonfig, Walter , Wiemann, Dagobert , Kapellen, Thomas M , Witsch, Michael , Schwab, Karl O , Holl, Reinhard W , initiative DPV-Science and the German Diabetes Research Center","journal_title":"Diabetes care","issn":"1935-5548 ; Electronic","isbn":"","publication_date":"20200601","volume":"43","issue":"6","first_page":"1311","page_count":"8","accession_number":"32229598","doi":"10.2337\/dc19-2022","publisher":"American Diabetes Association","doctype":"Historical Article; Journal Article","subjects":"Diabetes ","interest_area":["Endocrinology"," Pediatric Medicine"," Internal\/Family Medicine"," Pulmonology"],"abstract":"In 2017, the American Academy of Pediatrics introduced a new guideline (2017 Clinical Practice Guideline of the American Academy of Pediatrics [AAP 2017]) to diagnose arterial hypertension (HTN) in children that included revised, lower normative blood pressure (BP) values and cut points for diagnosing high BP in adolescents. We studied the impact of the new AAP 2017 on prevalence of HTN in children with type 1 diabetes mellitus (T1DM).","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=32229598&authtype=shib&custid=ns346513"}